跳至主要内容
临床试验/NCT03602807
NCT03602807Unknown不适用

Safety and Effect of Low-Energy Extracorporeal Shockwave Therapy (ESWT) on the Renal Allograft in Transplant Recipients - a Pilot Study.

Odense University Hospital2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2018年2月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
40
试验地点
2
主要终点
Change in renal clearance (GFR)

研究概览

简要总结

The aim is to investigate the safety and potential effect of Low-energy Shockwave Therapy (ESWT) on the transplanted kidney. The treatment consist of ESWT two times a week for three weeks, six treatments in total.

The hypothesis is that ESWT with improve the renal function, by reducing proteinuria (in a 24-hour urine collection test) and improving renal clearance of 51Cr-EDTA.

The safety of ESWT on the renal allograft will be assessed during and after treatments.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Minimum 1 year ago since last kidney transplant
  • P-Creatinin under 300, in the last 3 blood-samples
  • U-Albumine/creatinine ratio over 100, in the last 3 urine-samples

排除标准

  • Not Danish speaking.
  • Obstructive uropathy
  • Suspected autoimmune disease in the kidney graft
  • Symptomatic urinal tract infection (UTI)
  • Severe psychiatric disorder
  • Pregnant or planning on becoming pregnant

研究组 & 干预措施

Active treatment

Experimental

干预措施: Extracorporeal Shockwave Therapy (Device)

结局指标

主要结局

Change in renal clearance (GFR)

时间窗: At baseline and 3 months after treatment

Comparing GFR before and 3 months after treatment sessions

次要结局

  • Change in albumin/creatine ratio in 24hour urine sample(At baseline, 1 month after treatment and 3 months after treatment)
  • Incidens of treatment-related adverse events(up to 4 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ronja Niemann Lundrup

Undergraduate researcher, BSc.med

Odense University Hospital

研究点 (2)

Loading locations...

相似试验

Safety and Effect of Low-Energy Extracorporeal... | 临床试验